Calcineurin is a calcium-dependent protein phosphatase that plays an important role in cellular responses and calcium signal transduction. 1 Several studies have suggested that calcineurin is one of the key molecules in signal transduction in the brain and that dysfunction of calcineurin signaling could be linked to schizophrenia. 2, 3 Calcineurin is a heteromeric protein complex consisting of a catalytic subunit (calcineurin A) and a regulatory subunit (calcineurin B). 1, 4 PPP3CC encodes the calcineurin g-catalytic subunit and is located on chromosome 8p21.3 within a few cM of markers reported to be linked to schizophrenia. [5] [6] [7] 10 Gerber et al. 8 reported genetic associations of the PPP3CC gene with schizophrenia in populations from the United States and South Africa. However, only one replication study has been published, and these associations were not confirmed in 457 Japanese schizophrenic patients and 429 control subjects. 9 HapMap data indicated that a haplotype block spans almost the entire PPP3CC region in Japanese and European populations. The single nucleotide polymorphism (SNP) haplotype reported to be associated with schizophrenia by Gerber et al. 8 is located in the haplotype block. Therefore, we examined the associations in a large case-control study of 1645 schizophrenic patients and 1673 control subjects. This sample size has a power > 0.98 to replicate the haplotypic association with the same magnitude as that reported by Gerber et al., 8 assuming an a value = 0.05, two-tailed, a haplotype relative risk of 1.23, and haplotype frequency of 0.26 or effect size of 0.1. The haplotype frequency in the Japanese population was reported by Kinoshita et al.
9
All subjects were of Japanese descent and were recruited from the main island of Japan. The study included 1645 unrelated patients with schizophrenia (mean age7s.d., 48.2714.5 years; 899 men and 745 women) diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Control subjects were 1673 mentally healthy unrelated subjects (age, 47.9714.3, 886 men and 787 women) without self-reported family histories of mental illness within second-degree relatives. The subjects studied by Kinoshita et al. 9 were not included in the present study. The present study was approved by the Ethics Committees of the University of Tsukuba, Niigata University, Fujita Health University, Nagoya University, Okayama University and Teikyo University and all participants provided written informed consent. To rule out population stratification between patients and controls in the present study, 35 SNPs that are not in linkage disequilibrium (LD) with each other were genotyped in all samples and analyzed with the STRUCTURE program 2.0. 5 No stratification was observed. We genotyped five SNPs. SNP1 (rs10108011, CC21 in Gerber et al. 8 ) and SNP2 (rs2461491, CCS3 in Gerber et al.
8
) were selected because Gerber et al. 8 reported nominally significant allelic association of these SNPs with schizophrenia. SNP4 (rs2449340), SNP3 (rs2461490) and SNP5 (rs1116085) were genotyped to distinguish common haplotypes with frequencies X5% in the haplotype block based on HapMap data of the Japanese population. SNPs were genotyped with the TaqMan SNP Genotyping Assay (Applied Biosystems, Foster City, CA, USA) and ABI PRISM 7900HT Sequence Detection System (Applied Biosystems).
Deviation from predicted Hardy-Weinberg frequency was examined by w 2 -test. Individual allelic and genotypic associations were examined by Fisher's exact test. LD between polymorphisms and haplotypic associations were evaluated with Haploview software version 3.32. 6 To deal with multiple testing, allelic associations were evaluated by permutation tests implemented in Haploview. The genotype distributions were evaluated by the Cochran-Armitage test without correction for multiple testing.
The genotype and allele distributions of the five SNPs in the patient group and control group are shown in Table 1 . Distributions of these SNPs did not differ significantly from Hardy-Weinberg equilibrium. All five SNPs showed nominally significant allelic associations with schizophrenia and permutation tests revealed significant allelic associations of SNP1 (P = 0.012), SNP3 (P = 0.005) and SNP4 (P = 0.013) with schizophrenia. The genotype distributions suggest that the minor allele of each SNP is likely to have an additive effect in the susceptibility to schizophrenia. These five SNPs are in LD; however, the LD is not complete. Therefore, these associations were not caused by a single SNP in the present study. As shown in Table  2 , there were only two common haplotypes constructed from these SNPs. The most common haplotype in the control group was observed less frequently in the patient group (P = 0.034) and the second most common haplotype in the control group tended to be more frequently in the patient group (P = 0.079). A global P-value for the 5 SNP haplotype was 0.055.
Gerber et al. 8 found associations of the G allele of SNP1 (CC21) and the A allele of SNP2 (CCS3) with schizophrenia by transmission disequilibrium test. In the present study, we found that the G allele of SNP1 and the A allele of SNP2 occurred more frequently in the patient group than in the control group (P = 0.003, odds ratio (OR) = 1.15 for SNP1; P = 0.02, one-sided, OR = 1.10 for SNP2). Gerber et al. 8 found that the most common haplotype was overtransmitted to patients in their US population. According to the data reported by Kinoshita et al., 9 only two SNPs (SNP1 and SNP2 in the present study) are sufficient to distinguish the associated haplotype reported by Gerber et al. 8 from other haplotypes in the Japanese population. When haplotypes were constructed with SNP1 and SNP2, the haplotype that was the most common haplotype associated with schizophrenia in the US population was the second most common haplotype in our Japanese population. The second most common haplotype was more frequent in the patient group than in the control group (P = 0.036, two-sided) in the present study (Table 2) . Therefore, the present study replicates the allelic and haplotypic associations found in the US population described by Gerber et al., 8 although the ORs of the haplotype were lower in the present study (OR = 1.12) than in the study by Gerber et al. 8 (OR = 1.23). Kinoshita et al. 9 failed to replicate these associations. The OR of the G allele of SNP1 for schizophrenia COMT and RGS4 are promising candidate risk genes for schizophrenia 1 that impact on dopamine signaling [2] [3] [4] and on prefrontal function. 5, 6 While, in general, convergent molecular pathways and neurophysiological effects implicate gene Â gene interactions, there is growing evidence to support a specific direct interaction between risk alleles in COMT and RGS4. First, statistical epistasis between a number of putative schizophrenia risk genes, notably RGS4 and COMT, has been reported in risk for schizophrenia. 7 Second, a recent study in human postmortem dorsolateral prefrontal cortex demonstrated a significant correlation between both COMT val158met genotype and COMT enzyme activity and RGS4 mRNA levels, such that increased COMT enzyme activity (and Val allele load) predicted decreased RGS4 mRNA expression. 8 Using an fMRI working memory task in healthy subjects that robustly engages DLPFC in a manner sensitive to variation in both COMT and RGS4, we employed a moderated multiple regression approach to examine interactions between the COMT (rs4680 G/A(val158met)) and the RGS4 (rs951436 A/C ('Chowdari SNP4')), 9 SNPs most consistently associated with schizophrenia and with prefrontal activation. In line with earlier findings, we expected that the impact of genetic variation in RGS4 would be more pronounced on a COMT Val allele background, such that individuals with both RGS4 SNP4-A and COMT-Val would exhibit the most inefficient pattern of prefrontal cortical engagement (that is, greater prefrontal activation in the absence of performance differences). 10 We studied 82 healthy Caucasian subjects using an N-back working memory task as described previously. 10 Subjects were genotyped for RGS4 and COMT 5, 6 (COMT: 25 V/V, 43 V/M, 14 M/M; RGS4: 26 A/A, 36 A/C, 20 C/C). Since only two COMT Met/ Met-RGS4 A/A subjects were available in this sample, V/M heterozygote and M/M homozygote subjects were combined. One-way analysis of variance (ANO-VA) with five groups (COMT Val/Val, Met-carriers and RGS4 SNP4 A/A, A/C, C/C) revealed no significant between-group differences in performance (accuracy or reaction time), gender or age. Whole brain BOLD fMRI data were collected on a 3 T GE scanner (TE = 30 ms, TR = 2 s, flip angle = 90, FOV = 24 cm) while subjects performed an N-back working memory task (2-back and 0-back) as previously described. 10 A second level moderated multiple regression was used to map the main effects for
